• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

Editorial: Continuous CME

Article

As a sponsor of CME, Contemporary Pediatrics understands its responsibility to make CME relevant to the practicing pediatrician.

Related Videos
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
Ashley Gyura, DNP, CPNP-PC | Image Credit: Children's Minnesota
Congenital heart disease and associated genetic red flags
Traci Gonzales, MSN, APRN, CPNP-PC
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Related Content
Image Credit: © Artur - © Artur - stock.adobe.com.

Week in review: A new dermatology case study, and a new treatment for severe asthma

April 12th 2024
Article

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Joanne M. Howard, MSN, MA, RN, CPNP-PC, PMHS & Anne Craig, MSN, RN, CPNP-PC

Receptor targeting to identify medications for pediatric mental health concerns

April 12th 2024
Article

Psychopharmacologic agents used in the pediatric population from the perspective of their interactions with receptor targets in the brain and body.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
FDA approves benralizumab for children aged 6 to 11 years with severe asthma | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA approves benralizumab for children aged 6 to 11 years with severe asthma

April 11th 2024
Article

The FDA approval of benralizumab for patients ages 6 to 11 with asthma follows the conclusions of the phase 3 TATE study.

Understanding, addressing infection on Youth HIV Awareness Day | Image Credit: © Rana - © Rana - stock.adobe.com.

Understanding, addressing infection on Youth HIV Awareness Day

April 10th 2024
Article

The CDC's take on the importance of HIV awareness and testing among our youth.

© 2024 MJH Life Sciences

All rights reserved.